ES2052685T3 - Metodo para producir un adyuvante libre. - Google Patents

Metodo para producir un adyuvante libre.

Info

Publication number
ES2052685T3
ES2052685T3 ES88200443T ES88200443T ES2052685T3 ES 2052685 T3 ES2052685 T3 ES 2052685T3 ES 88200443 T ES88200443 T ES 88200443T ES 88200443 T ES88200443 T ES 88200443T ES 2052685 T3 ES2052685 T3 ES 2052685T3
Authority
ES
Spain
Prior art keywords
produce
free adjuvant
adjuvant
vaccines
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88200443T
Other languages
English (en)
Spanish (es)
Inventor
Eric Onno Rijke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of ES2052685T3 publication Critical patent/ES2052685T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES88200443T 1987-03-17 1988-03-09 Metodo para producir un adyuvante libre. Expired - Lifetime ES2052685T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8700629 1987-03-17

Publications (1)

Publication Number Publication Date
ES2052685T3 true ES2052685T3 (es) 1994-07-16

Family

ID=19849718

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88200443T Expired - Lifetime ES2052685T3 (es) 1987-03-17 1988-03-09 Metodo para producir un adyuvante libre.

Country Status (9)

Country Link
US (1) US5026543A (forum.php)
EP (1) EP0283085B1 (forum.php)
JP (1) JP2562827B2 (forum.php)
DE (1) DE3875762T2 (forum.php)
DK (1) DK167849B1 (forum.php)
ES (1) ES2052685T3 (forum.php)
GR (1) GR3007039T3 (forum.php)
HU (1) HU202119B (forum.php)
ZA (1) ZA881694B (forum.php)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
CN1120310A (zh) * 1993-03-11 1996-04-10 塞科雷泰克公司 在粘膜表面转运免疫原的聚合粘膜粘合剂
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
GB9417742D0 (en) * 1994-09-03 1994-10-19 Univ Nottingham Macrophage stimulating composition
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5891393A (en) * 1996-04-09 1999-04-06 The University Of North Carolina At Chapel Hill Method for the microbial decontamination of blood platelets
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
US6572874B1 (en) 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6416779B1 (en) 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
ES2311451T3 (es) * 1999-03-24 2009-02-16 The Secretary Of State For Defence Carbohidratos policationicos como immuestimulantes en vacunas.
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US6676958B2 (en) * 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
CA2513655C (en) 2003-01-21 2011-11-22 Chiron Corporation Use of tryptanthrin compounds for immune potentiation
US7893096B2 (en) 2003-03-28 2011-02-22 Novartis Vaccines And Diagnostics, Inc. Use of small molecule compounds for immunopotentiation
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
EP1765313A2 (en) 2004-06-24 2007-03-28 Novartis Vaccines and Diagnostics, Inc. Compounds for immunopotentiation
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
JP5214464B2 (ja) 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法
JP5394750B2 (ja) 2005-12-29 2014-01-22 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド 多価ｐｃｖ２免疫原性組成物及び当該組成物を製造する方法
KR20140019479A (ko) 2005-12-29 2014-02-14 베링거잉겔하임베트메디카인코퍼레이티드 돼지에서 임상 증상을 경감시키기 위한 ｐｃｖ2 면역원성 조성물의 용도
WO2007109812A2 (en) * 2006-03-23 2007-09-27 Novartis Ag Immunopotentiating compounds
US8173657B2 (en) * 2006-03-23 2012-05-08 Novartis Ag Imidazoquinoxaline compounds as immunomodulators
CA2647100A1 (en) * 2006-03-23 2007-09-27 Novartis Ag Methods for the preparation of imidazole-containing compounds
EP2101815A4 (en) 2006-12-11 2010-10-06 Boehringer Ingelheim Vetmed Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US20080292663A1 (en) * 2007-05-22 2008-11-27 Gerber Jay D Adjuvant compositions and methods for delivering vaccines
CA2712006A1 (en) 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
ES2467108T3 (es) 2008-12-09 2014-06-11 Gilead Sciences, Inc. Moduladores de receptores tipo toll
US9603919B2 (en) * 2009-03-31 2017-03-28 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Method for prophylaxis of influenza using vaccine for intranasal administration
PL2435554T3 (pl) 2009-05-26 2018-01-31 Advanced Bionutrition Corp Stabilna kompozycja suchego proszku zawierająca biologicznie aktywne mikroorganizmy i/lub materiały bioaktywne i sposoby jej wykonania
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CN102725393B (zh) 2010-01-28 2015-12-02 先进生物营养公司 包含生物活性材料的干燥玻璃质组合物
US20150044242A1 (en) 2012-03-12 2015-02-12 Advanced Bioadjuvants Llc Adjuvant and Vaccine Compositions
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
EP3052516B1 (en) 2013-10-02 2020-01-01 Boehringer Ingelheim Animal Health USA Inc. Pcv2 orf2 protein variant and virus like particles composed thereof
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
KR102685914B1 (ko) 2015-07-29 2024-07-16 어드밴스드 바이오뉴트리션 코프. 특수 식이 용도를 위한 안정한 프로바이오틱 건조 조성물
EP3801628A1 (en) 2018-06-04 2021-04-14 Apros Therapeutics, Inc. Tlr7 peptide conjugates
MX2020014087A (es) 2018-07-02 2021-04-12 Ayuvis Res Inc Moléculas inmunomoduladoras pequeñas novedosas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178350A (en) * 1961-05-15 1965-04-13 Cutler Lab Inc Biologic antigens adjuvanted with a colloidally water-soluble polymer of acrylic acidcrosslinked with polyallyl sucrose or polyallyl pentaerythritol
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
US3869546A (en) * 1972-12-22 1975-03-04 Cutter Lab Adjuvant compositions and medicinal mixtures comprising them
DE3308458A1 (de) * 1983-03-10 1984-09-13 Behringwerke Ag, 3550 Marburg Verfahren zur adjuvierung von vaccinen
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants

Also Published As

Publication number Publication date
DK141488A (da) 1988-09-18
HUT47224A (en) 1989-02-28
EP0283085B1 (en) 1992-11-11
ZA881694B (en) 1988-09-06
GR3007039T3 (forum.php) 1993-07-30
DK167849B1 (da) 1993-12-27
HU202119B (en) 1991-02-28
EP0283085A1 (en) 1988-09-21
DE3875762D1 (de) 1992-12-17
US5026543A (en) 1991-06-25
DE3875762T2 (de) 1993-05-13
JP2562827B2 (ja) 1996-12-11
DK141488D0 (da) 1988-03-15
JPS63253032A (ja) 1988-10-20

Similar Documents

Publication Publication Date Title
ES2052685T3 (es) Metodo para producir un adyuvante libre.
ES2080227T3 (es) Terpolimerizados del etileno, su fabricacion y el empleo de los mismos como aditivos para los destilados de aceite mineral.
ES2081411T3 (es) Procedimiento para la obtencion de poliisobuteno.
ES2137932T3 (es) Procedimiento para la preparacion de analogos de camptotecina solubles en agua, asi como los compuestos 10-hidroxi-11-alcoxi-6-camptotecina.
ATE42776T1 (de) Acrylfasern zur herstellung von kohlenstoffasern.
ES481541A1 (es) Un metodo de producir una guia de ondas optica de indice en gradiente.
BR8303580A (pt) Processo para inibir a mineralizacao de tecido natural fixado, bem como processo para inibir a calcinacao de tal tecido
ES2071351T3 (es) Un procedimiento para la produccion de 6,12-dihidro-6-hidroxicannabidiol y el uso del mismo para la produccion de trans-delta-9-tetrahidrocannabinol.
MX158513A (es) Procedimiento para producir un vulcanizado que tiene propiedades mejoradas
ES2158588T3 (es) Composiciones y procedimientos para el beneficio de menas.
ES2051862T3 (es) Un metodo para producir un medicamento que tiene un efecto catartico.
ES521895A0 (es) Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables.
MX9302076A (es) Proceso novedoso para preparar derivados de piperidina.
ES539963A0 (es) Un metodo para preparar un articulo conformado a partir de conposiciones fluoroelastomeras que contienen sulfonamidas fluoroalifaticas en calidad de agentes de curado.
PT88328A (pt) Processo para a preparacao de composicoes polimericas que endurecem por accao da agua contendo, como aditivos, modificadores polimericos do tipo polieterpolissiloxano-poliuretano
ES2053950T3 (es) Vacuna contra la coccidiosis.
CO5140125A1 (es) Metodo para la preparacion de eteres de arilo
ES521636A0 (es) Procedimiento de fabricacion de monoeter de monoetilenglicol.
ES2084101T3 (es) Fenoxialcanol como un estabilizante para isotiazolonas.
ES2078749T3 (es) Procedimiento para preparar sertralina.
ES2076320T3 (es) Adyuvante angiografico.
ES2131137T3 (es) Procedimiento para producir cromanos.
ES541611A0 (es) Un procedimiento para preparar alquilen-glicoles
ES2059711T3 (es) Metodo para la preparacion de una secuencia de acido nucleico codificante de un polipeptido de eimeria tenella.
ES2058269T3 (es) Di-t-butilfenil-alquil y -bencil-eteres.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 283085

Country of ref document: ES